000 01563 a2200457 4500
005 20250513150229.0
264 0 _c19980930
008 199809s 0 0 eng d
022 _a0305-7453
024 7 _a10.1093/jac/41.6.629
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPérez-Trallero, E
245 0 0 _aIn-vitro, in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniae.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cJun 1998
300 _a629-34 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAmoxicillin
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aCeftizoxime
_xanalogs & derivatives
650 0 4 _aCefuroxime
_xanalogs & derivatives
650 0 4 _aCephalosporins
_xpharmacology
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aPenicillin Resistance
650 0 4 _aRandom Allocation
650 0 4 _aSerum Bactericidal Test
650 0 4 _aStreptococcus pneumoniae
_xdrug effects
650 0 4 _aCefpodoxime Proxetil
700 1 _aAlkorta, M
700 1 _aGarcía-Arenzana, J M
700 1 _aIturzaeta, A
700 1 _aGomariz, M
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 41
_gno. 6
_gp. 629-34
856 4 0 _uhttps://doi.org/10.1093/jac/41.6.629
_zAvailable from publisher's website
999 _c9652801
_d9652801